Greenpro Capital Corp. filings document Current Reports on Form 8-K for material agreements, unregistered common-stock issuances and governance changes. The disclosures describe subscription agreements used for private placements, Securities Act exemptions under Regulation D and Regulation S, operating-capital use of proceeds, issued-and-outstanding share counts and related ownership information.
The filing record also covers acquisition agreements and minority investments, including the completed purchase of a small equity interest in Greenophene Technologies Limited, as well as board and committee changes. These filings frame Greenpro's capital structure, ownership and governance disclosures alongside its operating-company status as a Nevada corporation with Asian business-services and digital-finance activities.
Greenpro Capital Corp. Chief Executive Officer, President and director Lee Chong Kuang filed an amended Schedule 13D reporting his ownership in the company’s common stock. As of April 28, 2026, he beneficially owned 2,012,259 shares, or 11.16% of the outstanding common stock, based on 18,033,123 shares outstanding.
His stake includes 1,846,344 shares held directly and 165,915 shares held by his spouse, Yap Pei Ling, over which he may share voting and dispositive power. On April 28, 2026, he bought 107,310 shares from the company in a private placement at $2.3297 per share, investing $250,000 under a Subscription Agreement for investment purposes and to support the company’s operations.
Greenpro Capital Corp. reported a leadership change on its Board of Directors. Christopher Yu Nien Wong has notified the company that he will resign as a director effective April 30, 2026. He will also step down from the Audit, Compensation, and Nominating and Corporate Governance Committees on that date.
The company states that Mr. Wong’s resignation is not due to any disagreement regarding its operations, policies, or practices. Greenpro Capital is currently evaluating candidates to fill the resulting Board vacancy.
Greenpro Capital Corp. entered into and closed a small equity acquisition tied to a share issuance. On November 18, 2025, the company agreed to acquire 0.99% of Greenophene Technologies Limited (10 ordinary shares). On April 16, 2026, closing occurred and Greenpro issued 800,000 restricted common shares at $1.50 per share, valuing the consideration at $1,200,000. The shares were issued privately under Rule 506 of Regulation D as “restricted securities” under Rule 144. After the transaction, Greenpro had 17,925,813 common shares outstanding, and the seller held approximately 4.5% of the company’s common stock.
Greenpro Capital Corp. reported that BHL Ltd., a ten percent owner, holds 3,250,000 shares of Greenpro common stock. According to the filing, on March 31, 2026, BHL Ltd. received these shares in exchange for Greenpro’s acquisition of 520 ordinary shares, representing 5.2% of Forekast Limited from BHL Ltd.
Greenpro Capital Corp. completed a share exchange, issuing 8,500,000 shares of common stock to Forekast Limited shareholders for a 13.6% minority stake in Forekast as of March 31, 2026. The company received 1,360 Forekast ordinary shares and did not obtain control of Forekast.
This equity issuance increased Greenpro’s common shares outstanding from 8,625,813 on March 30, 2026 to 17,125,813 on the closing date, significantly diluting existing holders. New large shareholders include BHL Ltd. with 3,250,000 shares (18.98% of outstanding) and several other entities each holding 1,125,000 shares (6.57% each).
Greenpro Capital Corp. reports full-year 2025 results showing revenue of $2,073,557, down from $3,496,405 in 2024 as it continues focusing on advisory, consulting and venture activities across Asia. The company operates blockchain-based, Shariah-compliant security-token platform Green-X and maintains a broad network of corporate services and real-estate holding subsidiaries.
Greenpro’s venture portfolio has seen extensive write-downs, with multiple minority investments fully impaired in prior years and further small impairments in 2025, including the remaining $11,981 in Greenpro Trust and $92 in SEATech Ventures. In January 2025, it sold its fully impaired Jocom Holdings stake for $39,950, booking a $39,800 gain.
As of June 30, 2025, non-affiliate equity value was $7,592,303 at $1.57 per share, and 8,625,813 common shares were outstanding as of March 30, 2026. Post year-end, Greenpro agreed to issue 8,500,000 shares to acquire about 13.6% of Forekast Limited on a fully diluted basis, expanding its strategic investment portfolio.
Greenpro Capital Corp. furnished an information statement disclosing stockholder approval by written consent of a Share Exchange Agreement to acquire 1,360 ordinary shares of Forekast Limited (representing 13.6% of FKL) in exchange for 8,500,000 shares of Greenpro Common Stock.
The Board reported that the Majority Stockholders holding 4,463,908 shares (approximately 51.75%) executed the written consent. On a pro forma basis, Greenpro expects total shares outstanding of 17,125,813, with Exchange Share recipients holding 49.63% and existing shareholders holding 50.37%. The issuance will occur at closing, subject to closing conditions and Nasdaq listing approvals, and will be no earlier than twenty calendar days after mailing.
Greenpro Capital Corp. approved a Share Exchange under which the company will issue 8,500,000 shares of Common Stock in exchange for 1,360 Forekast Limited ordinary shares, representing approximately 49.63% of Greenpro's pro forma equity.
The Majority Stockholders, holding 4,463,908 shares (approximately 51.75%), executed written consent approving the transaction on February 9, 2026. Pro forma capitalization will be 17,125,813 shares outstanding after the issuance. The issuance exceeds 20% of pre-transaction outstanding shares, so the Company sought approval under Nasdaq Listing Rule 5635(a) and, to the extent applicable, 5635(d). The closing is subject to customary conditions and may not occur earlier than 20 calendar days after mailing this Information Statement.
Greenpro Capital Corp. plans a share exchange in which it will issue 8,500,000 new shares of common stock to the shareholders of Forekast Limited in return for 1,360 Forekast shares, equal to about 13.6% of Forekast’s equity. After closing, Exchange Share recipients are expected to own roughly 49.63% of Greenpro, with existing shareholders reduced to about 50.37%, resulting in substantial dilution. The board and holders of approximately 51.75% of Greenpro’s voting power have already approved the transaction by written consent. No shareholder vote or action is required, and no dissenters’ rights are available.
Greenpro Capital Corp. signed a Share Exchange Agreement to acquire a 13.6% fully diluted equity interest in Forekast Limited. In return, Greenpro will issue 8,500,000 shares of its common stock to Forekast’s shareholders at closing, subject to customary conditions and an outside closing date of March 31, 2026.